These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 31176775)

  • 1. CD155 expression in human breast cancer: Clinical significance and relevance to natural killer cell infiltration.
    Triki H; Charfi S; Bouzidi L; Ben Kridis W; Daoud J; Chaabane K; Sellami-Boudawara T; Rebai A; Cherif B
    Life Sci; 2019 Aug; 231():116543. PubMed ID: 31176775
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD155 expression and its prognostic value in postoperative patients with breast cancer.
    Yong H; Cheng R; Li X; Gao G; Jiang X; Cheng H; Zhou X; Zhao W
    Biomed Pharmacother; 2019 Jul; 115():108884. PubMed ID: 31035013
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overexpression of an Immune Checkpoint (CD155) in Breast Cancer Associated with Prognostic Significance and Exhausted Tumor-Infiltrating Lymphocytes: A Cohort Study.
    Li YC; Zhou Q; Song QK; Wang RB; Lyu S; Guan X; Zhao YJ; Wu JP
    J Immunol Res; 2020; 2020():3948928. PubMed ID: 32411795
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Primary human tumor cells expressing CD155 impair tumor targeting by down-regulating DNAM-1 on NK cells.
    Carlsten M; Norell H; Bryceson YT; Poschke I; Schedvins K; Ljunggren HG; Kiessling R; Malmberg KJ
    J Immunol; 2009 Oct; 183(8):4921-30. PubMed ID: 19801517
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DNAM-1/CD155 interactions promote cytokine and NK cell-mediated suppression of poorly immunogenic melanoma metastases.
    Chan CJ; Andrews DM; McLaughlin NM; Yagita H; Gilfillan S; Colonna M; Smyth MJ
    J Immunol; 2010 Jan; 184(2):902-11. PubMed ID: 20008292
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Essential role of CD155 glycosylation in functional binding to DNAM-1 on natural killer cells.
    Tahara S; Okumura G; Matsuo T; Shibuya A; Shibuya K
    Int Immunol; 2024 Apr; 36(6):317-325. PubMed ID: 38289706
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NK cells play a significant role in immunosurveillance at the early stage of MLL-AF9 acute myeloid leukemia via CD226/CD155 interactions.
    Wang Y; Chen C; Dong F; Ma S; Xu J; Gong Y; Cheng H; Zhou Y; Cheng T; Hao S
    Sci China Life Sci; 2015 Dec; 58(12):1288-98. PubMed ID: 26588911
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human CD96 Correlates to Natural Killer Cell Exhaustion and Predicts the Prognosis of Human Hepatocellular Carcinoma.
    Sun H; Huang Q; Huang M; Wen H; Lin R; Zheng M; Qu K; Li K; Wei H; Xiao W; Sun R; Tian Z; Sun C
    Hepatology; 2019 Jul; 70(1):168-183. PubMed ID: 30411378
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional characterization of DNAM-1 (CD226) interaction with its ligands PVR (CD155) and nectin-2 (PRR-2/CD112).
    Tahara-Hanaoka S; Shibuya K; Onoda Y; Zhang H; Yamazaki S; Miyamoto A; Honda S; Lanier LL; Shibuya A
    Int Immunol; 2004 Apr; 16(4):533-8. PubMed ID: 15039383
    [TBL] [Abstract][Full Text] [Related]  

  • 10. UPR decreases CD226 ligand CD155 expression and sensitivity to NK cell-mediated cytotoxicity in hepatoma cells.
    Gong J; Fang L; Liu R; Wang Y; Xing J; Chen Y; Zhuang R; Zhang Y; Zhang C; Yang A; Zhang X; Jin B; Chen L
    Eur J Immunol; 2014 Dec; 44(12):3758-67. PubMed ID: 25209846
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased Soluble CD226 in Sera of Patients with Cutaneous T-Cell Lymphoma Mediates Cytotoxic Activity against Tumor Cells via CD155.
    Takahashi N; Sugaya M; Suga H; Oka T; Kawaguchi M; Miyagaki T; Fujita H; Inozume T; Sato S
    J Invest Dermatol; 2017 Aug; 137(8):1766-1773. PubMed ID: 28395975
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification and functional analysis of ligands for natural killer cell activating receptors in colon carcinoma.
    Zhang Z; Su T; He L; Wang H; Ji G; Liu X; Zhang Y; Dong G
    Tohoku J Exp Med; 2012 Jan; 226(1):59-68. PubMed ID: 22189020
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contribution of inhibitory receptor TIGIT to NK cell education.
    He Y; Peng H; Sun R; Wei H; Ljunggren HG; Yokoyama WM; Tian Z
    J Autoimmun; 2017 Jul; 81():1-12. PubMed ID: 28438433
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decreased expression of DNAM-1 on NK cells from acute myeloid leukemia patients.
    Sanchez-Correa B; Gayoso I; Bergua JM; Casado JG; Morgado S; Solana R; Tarazona R
    Immunol Cell Biol; 2012 Jan; 90(1):109-15. PubMed ID: 21383766
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical significance of CD155 expression in human pancreatic cancer.
    Nishiwada S; Sho M; Yasuda S; Shimada K; Yamato I; Akahori T; Kinoshita S; Nagai M; Konishi N; Nakajima Y
    Anticancer Res; 2015 Apr; 35(4):2287-97. PubMed ID: 25862891
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic Value of Natural Killer Cells Besides Tumor-Infiltrating Lymphocytes in Breast Cancer Tissues.
    Bouzidi L; Triki H; Charfi S; Kridis WB; Derbel M; Ayadi L; Sellami-Boudawara T; Cherif B
    Clin Breast Cancer; 2021 Dec; 21(6):e738-e747. PubMed ID: 33727019
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD155, an onco-immunologic molecule in human tumors.
    Gao J; Zheng Q; Xin N; Wang W; Zhao C
    Cancer Sci; 2017 Oct; 108(10):1934-1938. PubMed ID: 28730595
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD155 immunoregulation as a target for natural killer cell immunotherapy in glioblastoma.
    Lupo KB; Matosevic S
    J Hematol Oncol; 2020 Jun; 13(1):76. PubMed ID: 32532329
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immune checkpoint CD155 promoter methylation profiling reveals cancer-associated behaviors within breast neoplasia.
    Triki H; Declerck K; Charfi S; Ben Kridis W; Chaabane K; Ben Halima S; Sellami T; Rebai A; Berghe WV; Cherif B
    Cancer Immunol Immunother; 2022 May; 71(5):1139-1155. PubMed ID: 34608548
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IL-15 and CD155 expression regulate LAT expression in murine DNAM1
    Luu TT; Wagner AK; Schmied L; Meinke S; Freund JE; Kambayashi T; Ravens I; Achour A; Bernhardt G; Chambers BJ; Höglund P; Kadri N
    Eur J Immunol; 2020 Apr; 50(4):494-504. PubMed ID: 31834938
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.